nicardipine has been researched along with Cerebrovascular Moyamoya Disease in 4 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moyamoya disease (MMD) and posterior reversible encephalopathy syndrome (PRES) share similar pathophysiological characteristics of endothelial dysfunction and impaired cerebral autoregulation." | 1.62 | Posterior reversible encephalopathy syndrome (PRES) in a patient with moyamoya disease: A case report. ( Chou, PS; Teng, CH; Wu, MN; Yang, IH, 2021) |
| "For the anesthetic management of moyamoya disease patients, especially in delivery, it is important to avoid hemodynamic changes and to maintain cerebral blood flow (CBF)." | 1.30 | Propofol anesthesia for cesarean section successfully managed in a patient with moyamoya disease. ( Furuya, A; Kumazawa, T; Matsukawa, T; Ozaki, M, 1998) |
| "There were no further episodes of transient ischemic attacks, seizures, or headache in one patient and decreased frequency in the other." | 1.29 | Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease. ( Fish, I; Forem, SL; Hosain, SA; Hughes, JT; Wisoff, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teng, CH | 1 |
| Yang, IH | 1 |
| Wu, MN | 1 |
| Chou, PS | 1 |
| Hosain, SA | 1 |
| Hughes, JT | 1 |
| Forem, SL | 1 |
| Wisoff, J | 1 |
| Fish, I | 1 |
| Moltó-Jordà, JM | 1 |
| Matías-Guiu, J | 1 |
| Furuya, A | 1 |
| Matsukawa, T | 1 |
| Ozaki, M | 1 |
| Kumazawa, T | 1 |
1 review available for nicardipine and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
[Nicardipine and its indications in neurology].
Topics: Brain Ischemia; Calcium Channel Blockers; Dementia; Epilepsy; Humans; Migraine Disorders; Moyamoya D | 1997 |
3 other studies available for nicardipine and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Posterior reversible encephalopathy syndrome (PRES) in a patient with moyamoya disease: A case report.
Topics: Adult; Antihypertensive Agents; Brain; Brain Edema; Diagnosis, Differential; Humans; Hypertension; M | 2021 |
Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease.
Topics: Carotid Stenosis; Cerebral Angiography; Cerebral Infarction; Cerebral Revascularization; Child; Comb | 1994 |
Propofol anesthesia for cesarean section successfully managed in a patient with moyamoya disease.
Topics: Adult; Analgesia, Obstetrical; Analgesics, Opioid; Anesthesia, Intravenous; Anesthesia, Obstetrical; | 1998 |